FABP4 and hepatocellular carcinoma: Jin et al. deemed that FABP4 promotes EMT by the AKT/GSK3 β/Snail signaling pathway in cervical squamous cell carcinoma [31], and Thompson et al. believed FABP4 promoted proliferation and migration of human hepatocellular carcinoma [29].